Gene · 970
NIH grants2,135
NIH grants whose papers are about the gene, through NIH's grant-paper links.
661 to 680 of 2,135
Download this page as JSON| Grant | Title | CD70 papers | Newest fiscal year |
|---|---|---|---|
| DP2HG010099 | In situ functional genomics to understand transcriptional regulation | 1 | 2022 |
| F31CA250401 | Development of Glypican-2 redirected T cells for the Treatment of Neuroblastoma | 1 | 2022 |
| F31DK123881 | The role of T cells in adipose tissue inflammation and insulin resistance during weight cycling | 1 | 2022 |
| F31HL156468 | Characterization and engineering of a compact genome editor for adeno-associated virus delivery to correct mutations causing cystic fibrosis | 1 | 2022 |
| F32HL154700 | Inflammation-associated anemia and the role of monocyte-derived inflammatory hemophagocytes in a model of blood-stage malaria | 1 | 2022 |
| K01HL140271 | The role of epigenetic transcriptional memory in monocyte-macrophage cells and cardiovascular disease risk | 1 | 2022 |
| K08CA248966 | Fc-enhanced CD40 agonist antibodies for immune modulation of the tumor microenvironment | 1 | 2022 |
| K23AI137183 | Role of B cell activating factor in non-infectious complications of common variable immunodeficiency | 1 | 2022 |
| K24AR063120 | Outcomes Research in Rheumatic Diseases | 1 | 2022 |
| K99DE030215 | Epstein-Barr Virus nuclear antigen leader protein in transcription regulation | 1 | 2022 |
| K99HG012203 | New approaches for leveraging single-cell data to identify disease-critical genes and gene sets | 1 | 2022 |
| OT2OD025337 | Research Matters: Creating Possibilities to Achieve Health and Wellness for All of Us Research Program | 1 | 2022 |
| OT2OD026550 | Trans-America Consortium of the Health Care Systems Research Network for the All of Us Research Program | 1 | 2022 |
| P01AG031862 | Epigenetics of Aging and Age-Associated Diseases | 1 | 2022 |
| P01AI138938 | Epitope-focused vaccine strategies against Zika virus | 1 | 2022 |
| P01CA217798 | Pancreatic Cancer Metastasis | 1 | 2022 |
| P01HL053749 | Lentiviral Gene Therapy for Sickle Cell Disease And Immunodeficiency Disorders | 1 | 2022 |
| P30DK079307 | Pittsburgh Center for Kidney Research | 1 | 2022 |
| P50CA107399 | City of Hope Lymphoma SPORE | 1 | 2022 |
| P50CA140388 | Administrative Supplement to MD Anderson Cancer Center Prostate Cancer SPORE | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/grants?page=34